Creators

Tamas Ham-Szabo

Visionary, Founder and CEO

@tamashamszabo 50 X followersFirst product launched 23mo ago

Total monthly visits
202.7K
Up10.5%MoMOct 2026MillionVerifier accounts for 91%
Public revenue
Undisclosed
No public revenue across products
Products
3
Since Dec 2024
Latest launch
19mo ago
AgentRunner<5K visits/mo
100% full-depth creator dossier open: complete product portfolio, 12-month combined traffic & MRR curves, shipping cadence, and timeline events.

Traffic

Portfolio · Last 12 months
Monthly visits

Products

Products and research metrics
ProductVisits · OctActions
MillionVerifierProtect your email reputation184.1K
SAAS FirstMaximize Customer Engagement with a Human-Led AI Agent Workforce18.6K
AgentRunnerSimplify Your AI App Development with Visual Prompt Engineering<5K

Timeline

Launches, marketing, revenue milestones, and pricing/plan/positioning changes across products
  1. Nov 1 · 17d ago

    • MillionVerifier Homepage headline (H1) changed to “Protect your email reputation”Positioning

      THE #1 EMAIL VERIFICATION SERVICE→Protect your email reputation

    • MillionVerifier Adopted technology: Cart FunctionalityFeatures

      —→Cart Functionality

    • MillionVerifier Adopted technology: Cloudflare Browser InsightsFeatures

      —→Cloudflare Browser Insights

    • MillionVerifier Adopted technology: Cloudflare TurnstileFeatures

      —→Cloudflare Turnstile

    • MillionVerifier Adopted technology: ExpressFeatures

      —→Express

Questions & evidence

What products has Tamas Ham-Szabo built?
Tamas Ham-Szabo tracks 3 standalone software products on EarlyLore (3 currently live), led by MillionVerifier, SAAS First, AgentRunner.
How much website traffic do Tamas Ham-Szabo's products get?
Across tracked standalone domains with web traffic estimates, Tamas Ham-Szabo's portfolio reaches 202.7K combined monthly visits in each site's latest observed month. Coverage excludes shared third-party hosts and store listings.

Related indie founder research guides

Evaluate your own SaaS idea →